Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is the first triple-agonist peptide to reach Phase 3 clinical trials, activating GLP-1, GIP, and glucagon receptors simultaneously
.png?w=1280&max-h=720&fit=crop&auto=format)
Addressing trauma or other factors that contributed to weight struggles
Individual eligibility, treatment response, side effects, weight-loss results, and insurance coverage vary
These symptoms are not unique to retatrutide and are commonly seen across GLP-1-based therapies
You may have dust, food, or liquid inside the pen
Related Reading Standard vs Microdose GLP-1: Semaglutide & Tirzepatide Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
